Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C-Reference-Cited by-同舟云学术

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

Published:2011-10-13 Issue:4 Volume:19 Page:244-253
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Sasso M.,Tengher-Barna I.,Ziol M.,Miette V.,Fournier C.,Sandrin L.,Poupon R.,Cardoso A.-C.,Marcellin P.,Douvin C.,de Ledinghen V.,Trinchet J.-C.,Beaugrand M.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2011.01534.x/fullpdf

Reference57 articles.

1. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data;Leandro;Gastroenterology,2006

2. Steatosis in chronic hepatitis C: why does it really matter?;Asselah;Gut,2006

3. Prevalence of fatty liver in a general population of Okinawa, Japan;Nomura;Jpn J Med,1988

4. Prevalence of and risk factors for hepatic steatosis in Northern Italy;Bellentani;Ann Intern Med,2000

5. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study;BMC Gastroenterology;2024-07-18

2. Ultrasound criteria for assessing the correction of metabolic-associated fatty liver disease and liver blood flow disorders using arginine in patients with coronary artery disease in combination with COVID-19;GASTROENTEROLOGY;2024-06-12

3. Nonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids;Journal of Clinical and Translational Hepatology;2024-03-18

4. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

5. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline;Hepatology;2024-03-15